Clinical Trial Update: Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy of HIPEC in colorectal cancer patients at high risk for peritoneal carcinomatosis is ongoing (recruiting).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Affiliated Cancer Hospital & Institute of Guangzhou Medical University | Conditions: Colorectal Cancer | Phase 3 | Status: RECRUITING